Radiology Across Borders’ Post

At Symbiosis Hospital, we recently achieved a remarkable milestone - the successful TAVI procedure on a patient weighing just 27 kg. This extraordinary case presented several clinical challenges, including extreme low weight/frailty, severe kyphosis, scoliosis, and a bent main artery caused by these conditions. Our expert team navigated these complexities with precision and care. Key to the procedure was the Right Valve Selection: Acurate neo 2 (AN2) (Boston Scientific), chosen for its superior trackability. We meticulously avoided aorta damage, ensuring a successful outcome despite the formidable hurdles. A testament to the efficacy of TAVI, the patient underwent the procedure on a Saturday and was walking home on Monday. This case showcases the remarkable capabilities of minimally invasive cardiac care. We extend our gratitude to our dedicated team: • Dr. Ankur Phatarpekar (Interventional Cardiologist) • Dr. Meghav Shah (Interventional Cardiologist) • Dr. Gourish Shinde (Cardiac Anaesthetist) Their expertise and commitment to providing the highest level of care made this success possible. #SymbiosisHospital #TAVI #CardiacCare #MedicalInnovation #PrecisionMedicine #HealthcareExcellence #Cardiology #MinimallyInvasive #acurateneo2

RABinar Success: "Don't Skip a Beat! Essential Findings Every Radiologist Should Look for in the Heart" presented by Dr. Matthew Aitken from Gold Coast University Hospital, Queensland, Australia, was a great session! Global Reach: 📊 Registrations: 400 👥 Participants: 142+ (plus 150 from multiple sites) 🌍 Countries: 34 Participant Feedback: 💬 “Thank you very much Dr. Aitken for sharing your knowledge and expertise and for the ‘Raygun thrombus’ chilling in someone else’s LV.” 💬 “I appreciate your inputs on this important topic. I can confidently put it into our practice.” Learning Outcomes: 🫀 Remember the heart exists—look at it properly! 🩺 Identify key cardiac findings on cross-sectional imaging. 💡 Make sensible recommendations based on cardiac findings. 🤝 Partners: Siemens Healthineers, I-MED Radiology Network, Australasian Sonographers Association, Lumus Imaging, Sonic Healthcare Foundation, Australian Diagnostic Imaging Association #CardiacImaging #RadiologyAcrossBorders #MedicalEducation #GlobalHealthcare #RadiologyTraining #RABinar #HealthcareImpact #RadiologistNetworking #HeartImaging

📢 Milestone alert: ONE THOUSAND patients and counting!! 🎉 We're thrilled to announce a monumental achievement in our journey towards revolutionizing cardiac care. Our noninvasive cardiac mapping technology has now been used in clinical studies in over 1000 patients with #cardiacarrhythmia, marking a significant milestone in our commitment to innovative healthcare solutions. 📆 Our journey began five years ago with a vision to transform the diagnosis and treatment of cardiac arrhythmias. Today, we stand proud as our technology is providing information for arrhythmia evaluation in several hospitals in an accurate, efficient, and safe fashion. 🚀 This achievement is not just a number—it's a testament to the trust the medical community is placing in our technology. It reflects the countless hours of research, development, and dedication from our team. More importantly, it signifies a commitment to improve the quality of life for patients suffering from cardiac arrhythmias, offering them hope and a path towards better health. 🙏 We want to extend our heartfelt thanks to all the healthcare professionals who have been part of this incredible journey. Your support and belief in our mission fuel our drive to innovate and push the boundaries of medical technology. Find more on our technology at #EHRA2024! #CardiacCare #Innovation #HealthcareTechnology #Milestone #NoninvasiveCardiacMapping #CardiacArrhythmia #MedicalDevice Hospital Clínic de Barcelona Hospital Gregorio Marañón Hospital La Fe de Valencia Hospital Universitari de Bellvitge Hospital Clínico Universitario Lozano Blesa Faculdade de Medicina da Universidade de Lisboa Sociedad Española de Cardiología European Society of Cardiology EIT Health

🌟 Exciting News Alert! 🌟 Thrilled to announce my new publication "Competing Risks for Monomorphic versus Non-Monomorphic Ventricular Arrhythmias in Primary Prevention Implantable Cardioverter Defibrillator Recipients: Global Electrical Heterogeneity and Clinical Outcomes (GEHCO) Study" in the EP Europace Journal. Our team has been dedicated to investigating critical aspects of cardiac health, and this study represents a significant step forward in understanding the complexities of ventricular arrhythmias among primary prevention implantable cardioverter defibrillator (ICD) recipients. 🔬 **Key Insights:** This comprehensive study delves into the competing risks associated with monomorphic versus non-monomorphic ventricular arrhythmias, shedding light on global electrical heterogeneity and its impact on clinical outcomes. Through meticulous analysis and robust data interpretation, we've uncovered valuable insights that could revolutionize risk assessment and patient care strategies. 💡 **Innovative Tools:** As part of this groundbreaking research, I had the privilege to contribute to the development of a sophisticated risk calculator using R Shiny. This tool, available at (https://lnkd.in/eBaqQMxp), empowers healthcare professionals with a user-friendly interface to estimate individualized risks and make informed decisions for their patients. Feel free to use the calculator and provide your thoughts. 📚 For those interested in delving deeper into our findings, the full article is available in EP Europace (https://lnkd.in/eaCqZF9D). Let's continue pushing the boundaries of knowledge and making a tangible difference in the lives of patients. #Cardiology #Research #MedicalScience #VentricularArrhythmias #ICD #HealthcareInnovation #RiskCalculator #GlobalCollaboration #Europace #ScienceAdvances

The Clinical Services In IR Task Force developed a three-stage system for clinical services infrastructure development. This system shall help create awareness of the fact that different levels of service provision can be offered and worked towards. IRs may also use this system to benchmark themselves and set personal goals for future developments in their centre and practice. The three levels of clinical services infrastructure are split into #inpatient and #outpatient. What is your current level? Where do you see yourself in three years from now? What helps you or holds you back? Leave a comment to share your experience! Learn more about the three-stage system here: https://t.ly/8EvkP Task force members: Prof. Dr. Andreas H. Mahnken, Alessandro Cannavale, Joo-Young Chun, Thierry De Baere, Rok Dezman, Stevo Duvnjak, Miltiadis (Miltos) Krokidis MD, PhD, EBIR-ES, FCIRSE, FRCR, FSIR, Maria Antonella Ruffino, MD, EBIR, FCIRSE, Anthony Ryan, José Urbano García #IRgoingClinical #interventionalradiology #IRad #ClinicalServicesInIR

Prof. Sohail Abrar shared his perspective at the 2nd Annual Pakistan Cardiac Imaging Summit, emphasizing the educational value of such gatherings. He highlighted the paramount importance of imaging in cardiac care, emphasizing that events like this summit provide invaluable learning opportunities. Prof. Abrar underscored how advancements in imaging technologies are vital for comprehensive cardiac evaluations and optimal patient management. #NICVD #CardiacImaging #PCIS2024

Exploring Cardiogenic Shock Treatment with Multi-Device Simulation #ComputationalLife In our latest breakthrough, we've digitally replicated a patient in the throes of cardiogenic shock to assess the efficacy of four distinct medical devices. Our visual graphs do more than just depict left ventricular volumes during a cardiac cycle – they provide critical insights that guide physicians towards the most impactful treatment options. The evidence is clear and corroborated by literature: ·      pVADs effectively reduce End-Diastolic Volume (EDV) without significantly affecting End-Systolic Volume (ESV). ·      IABP optimally decreases both EDV and ESV, improving cardiac function. ·      LVADs, with their unique triangular volume profiles, substantially reduce the overall volume in the left ventricle. ·      ECMO, specifically from the right atrium to the femoral artery, increases both ESV and EDV. These simulations are more than data – they are the future of personalized patient care, offering a window into the real-time impact of life-saving interventions. Delve into the intricacies of our pioneering research and be part of the conversation shaping the future of cardiac care. For continuous updates and insights, make sure to follow our LinkedIn page. #DigitalHealth #CardiogenicShock #MedicalSimulation #HealthcareInnovation #IABP #pVAD #LVAD #ECMO #CardiacCare"

Hot off the press!!! 🕹 #Radiation dose in #endovascular #aortic repair, an important topic 🏒 This study dives into the world of radiation dose of (complex) #EVAR and #TEVAR. The aim is to establish diagnostic reference levels (DRLs) for these interventions. DRLs serve as benchmarks to guide centers in assessing whether their radiation doses are high and if adjustments are needed to ensure safety. The study covers various factors influencing doses, including the type of intervention, equipment used, and more. Data from 3712 procedures across 24 centers were analyzed, revealing significant variations in radiation doses. The proposed DRL for KAP was 162 Gy cm2, 175 Gy cm2 and 266 Gy cm2 for standard EVAR, TEVAR and BEVAR/FEVAR, respectively. This study shows that endovascular aortic procedures can be associated with significant radiation doses and that there are large inter-centre dose variations. Developing DRLs pertinent to those procedures is essential to optimise the radiation risks to patients and staff while maintaining the highest standard of patient care. Congratulations to the authors: Dr Yvonne Tsitsiou, Bar Velan, Rebecca Ross, Raghu Lakshminarayan, Andy Rogers and Mo Hamady Link to article: https://lnkd.in/embxE4q8 Aortic Center LUMC Imperial College London Hull University Teaching Hospitals NHS Trust Nottingham University Hospitals NHS Trust

I’m thrilled to share the news of our new global distribution and marketing agreement with ASCEND Cardiovascular, one of the most respected leaders in heart diagnostic care. This partnership marks a significant milestone in bringing our AI-powered heart-scanning technology, which transforms ultrasound images into MRI-quality heart scans, to healthcare facilities across North America. 🤝 What This Partnership Means: Integration with Top-tier Technology: ASCEND Cardiovascular, renowned for its cardiovascular procedure and reporting solutions, will integrate Ventripoint’s technology into its expansive IT platform, already a staple used by 50,000 hospitals, clinics, and caregivers. Wider Access: Our VMS+ system, which transforms ultrasound images into MRI-quality heart images, will now be more accessible to cardiologists and healthcare professionals. Joint Efforts in Healthcare Innovation: Together with ASCEND, we aim to enhance cardiac care, reduce diagnostic times, and improve overall patient outcomes. 💡 Key Highlights: Initial Two-Year Term: Focused on the North American markets, this agreement sets the stage for broader, global impacts in the future. Expert Collaboration: With ASCEND’s expertise in healthcare IT and our innovative heart-imaging technology, we are set to transform cardiac diagnostics. 🗣️ From Jeffrey Soble, MD, President & CEO of ASCEND: “Our aim is to provide clinicians with reliable and effective tools on a global scale.” 🌍 Stay tuned for more updates on this exciting collaboration! #VentripointDiagnostics #ASCENDCardiovascular #HealthcareInnovation #CardiacCare #AIMedicalTechnology  

OCCUPI, an Investigator Initiated Study led by Dr BK Kim (Severance Hospital, S Korea) was presented as a late-breaker at just concluded ESC. The study which was also simultaneously published in prestigious Lancet demonstrated that OCT-guided PCI significantly improves clinical outcomes and enhances safety and effectiveness of coronary stenting compared to conventional angiography-guided PCI in complex cases. The data was presented just a couple of days after the revision of ESC guidelines for the treatment of CCS, which revised the Intravascular Imaging (OCT/IVUS for complex lesion) to the highest possible level IA. The results from OCCUPI and the new recommendations will likely change the practice of PCI with DES for complex coronary lesions by providing stronger support for the superior benefits of OCT guidance over conventional angio-guided PCI. Many congratulations to the Investigators of OCCUPI for running this large RCT.. #OCT #ComplexPCI #DES #ESC2024 #InvestigatorInitiatedStudy #Abbottproud